Assessing yellow fever risk in the Ecuadorian Amazon
Izurieta RO, Macaluso M, Watts DM, Tesh RB, Guerra B, Cruz LM, Galwankar S, Vermund SH. Assessing yellow fever risk in the Ecuadorian Amazon. Journal Of Global Infectious Diseases 2009, 1: 7-13. PMID: 20300380, PMCID: PMC2840941, DOI: 10.4103/0974-777x.49188.Peer-Reviewed Original ResearchYellow fever casesYellow fever infectionFever infectionFever casesSerum glutamic oxaloacetic transaminaseSerum glutamic pyruvicHumoral immune responseCross-sectional studyDengue-2 infectionsIgG-specific antibodiesGlutamic oxaloacetic transaminaseYellow fever outbreaksYellow fever riskMilitary personnelSeroepidemiological methodsClinical symptomsRisk factorsImmune responseOxaloacetic transaminaseGlutamic pyruvicFever riskFever outbreakAttack rateSpecific antibodiesYellow feverAnamnestic immune response to dengue and decreased severity of yellow fever
Izurieta RO, Macaluso M, Watts DM, Tesh RB, Guerra B, Cruz LM, Galwankar S, Vermund SH. Anamnestic immune response to dengue and decreased severity of yellow fever. Journal Of Global Infectious Diseases 2009, 1: 111-116. PMID: 20300401, PMCID: PMC2840959, DOI: 10.4103/0974-777x.56257.Peer-Reviewed Original ResearchYellow fever infectionAnamnestic immune responseFever infectionDengue antibodiesImmune responseProtective immunityYellow feverDengue type 2 virusYellow fever casesHumoral immune responseCross-sectional studyDengue-2 infectionsPresence of antibodiesIgG-specific antibodiesCross-reactive antibodiesType 2 virusSeroepidemiological methodsLog-linear regression analysisDengue immunityDengue infectionSevere diseaseStudy populationFever casesSeroepidemiological surveyFever